Back to Journals » OncoTargets and Therapy » Volume 6

 Telangiectatic osteosarcoma: a review of literature

Authors Liu J, Liu S, Wang J, Zhu W, Hua Y, Sun W, Cai Z

Received 9 December 2012

Accepted for publication 4 February 2013

Published 28 May 2013 Volume 2013:6 Pages 593—602

DOI https://doi.org/10.2147/OTT.S41351

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 3



Jun-jian Liu,1* Shen Liu,2* Jian-guang Wang,1 Wei Zhu,1 Ying-qi Hua,1 Wei Sun,1 Zheng-dong Cai1

1
Department of Orthopedic Surgery, Shanghai Tenth People’s Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China; 2Department of Orthopedics, the Sixth Affiliated People’s Hospital, Shanghai Jiaotong University Schoolof Medicine, Shanghai, People’s Republic of China 

*These authors contributed equally to this work

Abstract: Telangiectatic osteosarcoma is a rare variant of osteosarcoma and hence its occurrence, presentation, and prognosis are poorly understood. With advancements in technology and available treatment options, the scenario of its diagnosis, management, and outcome has changed. Chemotherapy with surgery was challenged previously, but has now been proved to be beneficial. We reviewed the available literature and compared results to define the characteristics of the disease, its presentation, radiographic and pathologic features, optimal treatment, and prognosis.

Keywords: telangiectatic osteosarcoma, osteosarcoma, radiology

Creative Commons License © 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.